Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 321 Billerica Road, Suite 204 CHELMSFORD MA 01824 |
Tel: | N/A |
Website: | https://cannabistcompany.com |
IR: | See website |
Key People | ||
Michael Abbott Executive Chairman of the Board | Jesse Channon President | David J. Hart Chief Executive Officer |
Derek Watson Chief Financial Officer | Bryan Olson Chief People and Administrative Officer | David Sirolly Chief Legal Officer and General Counsel | Guy Hussussian Chief Data Officer |
Business Overview |
The Cannabist Company Holdings Inc. is a cultivator, manufacturer and provider of cannabis products and related services, with licenses in 15 United States jurisdictions. The Company's principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The Company operates approximately 124 facilities, including 93 dispensaries and 31 cultivation and manufacturing facilities, including those under development. The Company is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The Company offers products spanning flower, edibles, oils and tablets, and manufactures brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. |
Financial Overview |
For the fiscal year ended 31 December 2023, Cannabist Company Holdings Inc revenues decreased less than 1% to $511.3M. Net loss decreased 58% to $175.7M. Revenues reflect market conditions. Lower net loss reflects Goodwill impairment decrease of 89% to $19.3M (expense), Intangible impairment decrease of 73% to $46.2M (expense), Salaries and benefits decrease of 28% to $90.3M (expense). |
Employees: | 2,191 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $619.89M as of Dec 31, 2023 |
Annual revenue (TTM): | $701.69M as of Dec 31, 2023 |
EBITDA (TTM): | $59.15M as of Dec 31, 2023 |
Net annual income (TTM): | -$241.13M as of Dec 31, 2023 |
Free cash flow (TTM): | -$3.42M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $437.56M as of Dec 31, 2023 |
Shares outstanding: | 458,024,501 as of Mar 11, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |